In Silico Tools in PROTACs design

Mengman Wei

2023-07-09

Abstract:PROTACs, as a highly promising new. therapeutic paradigm, have attracted widespread attention from the academic and pharmaceutical communities in recent years. To date, the design and validation of PROTACs molecule's druggability primarily rely on experimental approaches, making the development process of this kind of drug molecule time-consuming. Computer-aided tools for PROTACs design may offer a potential solution to expedite the design process and enhance its efficiency. This mini review briefly summarizes the in silico tools for PROTACs drug molecule design reported recently.

Biomolecules

What problem does this paper attempt to address?

The problem this paper attempts to address is: how to use computer-aided tools to accelerate the design process of PROTAC (PROteolysis TArgeting Chimeras) molecules and improve their design efficiency.

Specifically, PROTAC is an emerging therapeutic molecule that mimics natural processes to selectively remove pathogenic proteins using the body's protein degradation mechanism. However, the current design and validation of PROTACs mainly rely on experimental methods, making the drug molecule development process very time-consuming. Therefore, this paper summarizes the computer-aided tools reported in recent years for the design of PROTAC molecules and explores whether these tools can provide valuable insights for the design process.

The main content of the paper includes:
1. **Basic principles of PROTAC**: Introduction to the composition and mechanism of action of PROTAC.
2. **Computer-aided design tools**: Summarizes computational methods used for selecting PROTAC components, predicting and evaluating molecular efficacy, and pharmacological properties.
3. **Linker design**: Discusses the selection and generation algorithms of linkers, especially machine learning-based methods like DeLinker.
4. **Prediction and evaluation of degradation efficiency**: Introduces various computational methods, such as molecular dynamics simulations and machine learning models, used to assess the degradation efficiency of PROTAC molecules.
5. **Prediction and evaluation of drug-likeness**: Discusses how to evaluate the physicochemical properties, ADMET (absorption, distribution, metabolism, excretion, and toxicity) characteristics of PROTAC molecules to determine their feasibility as drugs.

Through this content, the paper aims to provide researchers with a systematic approach to using computer-aided tools to optimize the design process of PROTACs, thereby accelerating their application in drug development.